These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 6172610

  • 21. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant.
    Fritz RB, Chou CH, McFarlin DE.
    J Immunol; 1983 Jan; 130(1):191-4. PubMed ID: 6183347
    [Abstract] [Full Text] [Related]

  • 22. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
    Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE.
    J Immunol; 1995 Jan 01; 154(1):450-8. PubMed ID: 7527821
    [Abstract] [Full Text] [Related]

  • 23. Maternal deprivation and early weaning modulate experimental allergic encephalomyelitis in the rat.
    Laban O, Marković BM, Dimitrijević M, Janković BD.
    Brain Behav Immun; 1995 Mar 01; 9(1):9-19. PubMed ID: 7542507
    [Abstract] [Full Text] [Related]

  • 24. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY, Yang JS, Huang YM, Levi M, Link H, Xiao BG.
    Clin Immunol; 2000 Sep 01; 96(3):205-11. PubMed ID: 10964538
    [Abstract] [Full Text] [Related]

  • 25. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S, Kibler RF, Morrison DC.
    J Immunol; 1982 May 01; 128(5):2073-80. PubMed ID: 6174621
    [Abstract] [Full Text] [Related]

  • 26. Experimental allergic encephalomyelitis and vaccination-induced resistance in DA rats.
    Bouwer HG, Hinrichs DJ.
    Cell Immunol; 1997 Jan 10; 175(1):92-8. PubMed ID: 9015193
    [Abstract] [Full Text] [Related]

  • 27. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.
    Levine S, Sowinski R.
    Arch Int Pharmacodyn Ther; 1977 Dec 10; 230(2):309-18. PubMed ID: 603323
    [Abstract] [Full Text] [Related]

  • 28. Suppression of experimental allergic encephalomyelitis in guinea-pigs with poly-L-lysine.
    Chelmicka-Szorc E, Arnason BG.
    Clin Exp Immunol; 1975 Dec 10; 22(3):539-45. PubMed ID: 5213
    [Abstract] [Full Text] [Related]

  • 29. Chronic experimental allergic encephalomyelitis in guinea pigs: immunologic studies on the two major myelin proteins.
    Cambi F, Lees MB.
    Cell Immunol; 1984 Jul 10; 86(2):567-74. PubMed ID: 6203654
    [Abstract] [Full Text] [Related]

  • 30. Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats.
    Rivero VE, Maccioni M, Bucher AE, Roth GA, Riera CM.
    J Neuroimmunol; 1997 Jan 10; 72(1):3-10. PubMed ID: 9003240
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Immunodepressive action of prospidin].
    Filitis LN, Pereshin GN.
    Farmakol Toksikol; 1977 Jan 10; 40(1):89-92. PubMed ID: 852552
    [No Abstract] [Full Text] [Related]

  • 33. Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.
    Vogel CL, De Vita VT, Lisak RP, Kies MW.
    Cancer Res; 1969 Dec 10; 29(12):2249-53. PubMed ID: 5369677
    [No Abstract] [Full Text] [Related]

  • 34. Facilitatory and inhibitory effects of phytohemagglutinin on experimental allergic encephalomyelitis in guinea pigs.
    Shaw CM.
    J Immunol; 1969 Jan 10; 102(1):63-8. PubMed ID: 4974699
    [No Abstract] [Full Text] [Related]

  • 35. Cyclophosphamide in allergic encephalomyelitis in chickens.
    Błaszczyk B, Giełdanowski J, Viljanen M, Karakoz I, Katkiewicz M, Lemmel EM.
    Arch Immunol Ther Exp (Warsz); 1986 Jan 10; 34(3):369-75. PubMed ID: 3592938
    [Abstract] [Full Text] [Related]

  • 36. Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier.
    Osanai T, Nagai Y.
    Neurochem Res; 1984 Oct 10; 9(10):1407-16. PubMed ID: 6514110
    [Abstract] [Full Text] [Related]

  • 37. Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.
    Paterson PY, Hanson MA.
    J Immunol; 1969 Oct 10; 103(4):795-803. PubMed ID: 5349735
    [No Abstract] [Full Text] [Related]

  • 38. Immunosuppressive activity of cyclic imides in laboratory animals.
    Mückter H, Frankus E, Graudums I, Krüpe W, Heydenreich M, Osterloh G, Felgenhauer F, Lagler F, Helm F.
    Int J Lepr Other Mycobact Dis; 1971 Oct 10; 39(2):377-80. PubMed ID: 4948081
    [No Abstract] [Full Text] [Related]

  • 39. [Prevention of experimental allergic encephalomyelitis by immunological technics].
    Pellet H, Brun M, Camargo R, Girard P.
    Rev Neurol (Paris); 1968 Feb 10; 118(2):133-40. PubMed ID: 4301748
    [No Abstract] [Full Text] [Related]

  • 40. Experimental allergic encephalomyelitis. V. Therapeutic attempts with immunosuppressive and antiinflammatory drugs.
    Anghelescu N, Petrescu A, Chimion D.
    Neurol Psychiatr (Bucur); 1979 Feb 10; 17(2):99-105. PubMed ID: 482840
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.